Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00652210 · ClinicalTrials.gov registry record · Phase 1
Use of Multiphoton Microscopy in the Diagnosis of Cancer
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 344
- Enrollment target
NCT00652210 is a Phase 1 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 344 participants.
The verdict
NCT00652210, a Phase 1 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 344 participants
- Enrollment target
Study Summary
Multiphoton microscopy (MPM) has been shown to be able to image tissue at a cellular level. Our project will initially evaluated the ability of MPM imaging to distinguish normal bladder urothelium from atypical and malignant urothelium in the ex vivo setting. After development of sufficient criteria, we plan to develop an endoscopic bladder probe that will provide a non-invasive means to image the interior of the bladder at the cellular level, which would provide direct evidence of the presence of tumor without a biopsy. After exhibiting usefulness of MPM imaging for bladder cancer, we will look at other organs beginning with the colon.
Interventions
- OTHER Multiphoton microscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2005-06 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00652210
The ClinicalTrials.gov registry entry for NCT00652210 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multiphoton microscopy is the first listed.
NCT00652210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00652210 about?
NCT00652210 is a clinical study titled "Use of Multiphoton Microscopy in the Diagnosis of Cancer". Multiphoton microscopy (MPM) has been shown to be able to image tissue at a cellular level. Our project will initially evaluated the ability of MPM imaging to distinguish normal bladder urothelium from atypical and malignant urothelium in the ex vivo setting. After development of sufficient criteria...
What is the current status of trial NCT00652210?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 344 participants. The study started on 2005-06. Estimated completion is 2015-09.
What interventions are being tested in trial NCT00652210?
The interventions under investigation include: Multiphoton microscopy (OTHER).
Who is sponsoring clinical trial NCT00652210?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.